| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.025 | 0.7 |